Home » Topics » Regulatory » Patents

Patents
RSS

Novel tyrosine-protein kinase SYK inhibitors designed by GSK

Nov. 24, 2011

Astellas Pharma prepares novel NPT-IIb inhibitors

Nov. 24, 2011

New compounds for bone disorders prepared by Daiichi Sankyo

Nov. 24, 2011

Compounds that modulate skeletal muscle contractility disclosed by Cytokinetics

Nov. 23, 2011

Japanese researchers prepare novel Toll-like receptor antagonists

Nov. 23, 2011

New steroidal lactones from M. crassissima disclosed by PharmaMar

Nov. 23, 2011

New lysophospholipid S1P1 receptor modulators disclosed by Allergan

Nov. 23, 2011

Merck & Co. designs novel beta3-adrenoceptor agonists

Nov. 23, 2011

Novel modulators of skeletal muscle contractility patented by Cytokinetics

Nov. 22, 2011

PharmacoFore discloses new tapentadol prodrugs for pain

Nov. 22, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...